Deniz Kent, Ph.D.
FounderFounder at Prolific Machines
Berkeley, California, United States
FoundedProlific Machines
About
Deniz Kent, Ph.D., is CEO and Co-Founder of Prolific Machines Inc., a company developing optogenetic biomanufacturing, which uses light to control proteins within cells in bioreactor settings. Kent conceived the idea for the company, whose reported work includes monoclonal antibody production, light-guided glycoengineering, the manufacture of certain difficult-to-produce biotherapeutics, and light-guided virus manufacturing aimed at AAV gene therapy.
Founder at Prolific Machines
Intro paths
→
In turn, Deniz can intro founders to Prolific Machines's investors below.
Prolific Machines's investors · 6
Baruch Future VenturesSan Francisco · $100K – $1M checks · since 2024Breakthrough Energy VenturesBoston · $500K – $50M checks · since 2024Darco CapitalPhiladelphia · since 2024Mayfield FundCupertino · $500K – $12M checks · since 2024Solari CapitalNew York · since 2024Tet VenturesBerlin · $50K – $250K checks · since 2024
Co-founders at Prolific Machines
MH
Maximilian Hörner
MH
Max HuismanChief Technology Officer & Co-Founder
DK
Deniz KentChief Executive Officer & Co-Founder
DJ
Declan JonesFounder
Experience
- Prolific Machines Inc.CEO & Co-Foundercurrent2020 — presentBerkeley, California, United States
- UnreasonableUnreasonable Fellowcurrent2024 — present
- Founders PledgeFounders Pledge Membercurrent2024 — present
- IndieBioIndieBio Batch 11 Startup Accelerator2020 — 2021
- King's College LondonPhD at the Centre for Stem Cells and Regenerative Medicine2016 — 2020Center for Stem Cells and Regenerative Medicine
- University of Massachusetts Medical SchoolVisiting Scholar2019
- GIANT Health EventsSenior Conference Organiser (Part Time)2016 — 2017
- University of BristolResearcher at the Morgan Tumour Immunology Lab2014 — 2016
- Synapse MagazineScientific Journalist2014 — 2016
- GSKScientist2014 — 2015Stevenage, England, United Kingdom
- Sanofi PasteurIntern2012
Skills & more
Research32Immunology27Asthma7Molecular Biology21Oncology6Drug Discovery5Clinical Trials3Public Speaking5Scientific Writing3Dendritic Cells2Microsoft Office1Cell Biology2
+3 more
BiotechnologyLife SciencesConfocal MicroscopyLanguages English · Turkish
From Deniz's professional profile.
Frequently asked questions
- Who is Deniz Kent, Ph.D.?
- Deniz Kent, Ph.D., is CEO and Co-Founder of Prolific Machines Inc., a company developing optogenetic biomanufacturing, which uses light to control proteins within cells in bioreactor settings. Kent conceived the idea for the company, whose reported work includes monoclonal antibody production, light-guided glycoengineering, the manufacture of certain difficult-to-produce biotherapeutics, and light-guided virus manufacturing aimed at AAV gene therapy.
- Where does Deniz Kent, Ph.D. work?
- Deniz Kent, Ph.D. is Founder of Prolific Machines.
- What companies did Deniz Kent, Ph.D. found?
- Deniz Kent, Ph.D. founded Prolific Machines.
- Where did Deniz Kent, Ph.D. go to school?
- Deniz Kent, Ph.D. studied at King's College London (Doctor of Philosophy (Ph.D.), Stem Cell Biology); King's College London (Masters in Biomedical and translational science); University of Bristol (Bachelor's degree, Cellular and Molecular Medicine).
Same school
Also attended King's College London293
Harry StebbingsFounder & General Partner at 20VCDominic JacquessonInvestor at Index VenturesJohn HortonInvestor at DN CapitalBob ThomasPartner at OxxKatherineHealthcare Investment Lead at Hummingbird VenturesÖzge Gizem YerlikayaGeneral Counsel at Idacapital
.avif)
+ 287 more
Also attended University of Bristol251
Chris BischoffInvestment Team at General CatalystSaran DaviesInvestor at Moonfire VenturesThomas RubensInvestor at DN CapitalAnnabel StoddartOffice Manager and Executive Assistant at Medical Excellence CapitalMichael PatersonCo-Founder & former CTO of BeameryMaxim SirenkoVenture Partner at DFJ
.jpg)
+ 245 more
Shared employers
Also worked at Founders Pledge71
Rouven DresselhausInvestor at Cavalry VenturesStefan WalterInvestor at Cavalry VenturesNick FitzInvestor at Juniper Ventures Management, LlcGriff BohmInvestor at Juniper Ventures Management, LlcStacy BrunnerHead of Marketing at Emerald Technology Ventures AgAndrew McLoughlinBrit in San Francisco; seed-stage venture capital investor
+ 65 more
Also worked at IndieBio17
Michelle ModestInvestor at Alpha PartnersPae WuGeneral Partner at SOSVPo BronsonGeneral Partner at SOSVMohan S. IyerGeneral Partner at SOSVJames CaffynPartner at Lever VCThomas NagyOperational Partner at Astanor Ventures
+ 11 more
